Clinical trial
Use of Beta-blockers and Risk of New Onset Diabetes
NCT01587638 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Beta-blockers and Risk of New Onset Diabetes
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- December 31, 2009
- Enrollment
- 12,336 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.